Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TopQ Cut-off Determination Study For 3D-OCT 1 Maestro and 3D OCT-2000

NCT02203981 is registered in ClinicalTrials.gov with Topcon Medical Systems, Inc. as lead sponsor.

NCT NCT02203981
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02203981 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TopQ Cut-off Determination Study For 3D-OCT 1 Maestro and 3D OCT-2000
Lead sponsor
Topcon Medical Systems, Inc.
Phase
Observational
Overall status
Completed
Start date
January 31, 2014
Completion date
August 31, 2014
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy